0001209191-19-007450.txt : 20190205 0001209191-19-007450.hdr.sgml : 20190205 20190205174812 ACCESSION NUMBER: 0001209191-19-007450 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190201 FILED AS OF DATE: 20190205 DATE AS OF CHANGE: 20190205 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HELLUMS RHONDA LYNETTE CENTRAL INDEX KEY: 0001766456 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35952 FILM NUMBER: 19569100 MAIL ADDRESS: STREET 1: C/O ARATANA THERAPEUTICS, INC. STREET 2: 11400 TOMAHAWK CREEK PARKWAY, SUITE 340 CITY: LEAWOOD STATE: KS ZIP: 66211 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ARATANA THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001509190 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 383826477 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11400 TOMAHAWK CREEK PARKWAY, SUITE 340 CITY: LEAWOOD STATE: KS ZIP: 66211 BUSINESS PHONE: 913.353.1000 MAIL ADDRESS: STREET 1: 11400 TOMAHAWK CREEK PARKWAY, SUITE 340 CITY: LEAWOOD STATE: KS ZIP: 66211 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-02-01 0 0001509190 ARATANA THERAPEUTICS, INC. PETX 0001766456 HELLUMS RHONDA LYNETTE C/O ARATANA THERAPEUTICS, INC. 11400 TOMAHAWK CREEK PARKWAY, SUITE 340 LEAWOOD KS 66211 0 1 0 0 CHIEF FINANCIAL OFFICER Common Stock 2019-02-01 4 A 0 24923 0.00 A 51424 D Stock Option (Right to Buy) 4.44 2019-02-01 4 A 0 67527 0.00 A 2029-01-31 Common Stock 67527 67527 D Vests as to 25% of the total number of shares (rounded down to the nearest whole share) on February 1, 2020 and as to an additional 1/48th of the total number of shares (rounded down to the nearest whole share) on the same day of each of the 36 successive calendar months thereafter, such that the stock option shall be vested as to all shares on February 1, 2023, subject to continued service with the Issuer through the applicable vesting dates. /s/ John C. Ayres as Attorney-in-Fact for Rhonda Lynette Hellums 2019-02-05